AbbVie

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 57,000 full-time employees. The company went IPO on 2013-01-02. The company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. The aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Duodopa is a levodopa-carbidopa intestinal gel for the treatment of Parkinson's disease. Eye care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, and Restasis. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its pipeline also includes zumilokibart and APG273.

AbbVie, Inc. adalah perusahaan biopharmaceutical berbasis riset yang bergerak dalam pengembangan dan penjualan produk farmasi. Perusahaan ini berkantor pusat di North Chicago, Illinois dan saat ini mempekerjakan 57.000 karyawan tetap. Perusahaan ini terdaftar di bursa saham pada 02 Januari 2013. Perusahaan ini terlibat dalam penelitian dan pengembangan, manufaktur, komersialisasi, dan penjualan obat-obatan dan terapi. Portofolio produknya mencakup Imunologi, Onkologi, Estetika, Ilmu Saraf, Perawatan Mata, dan Produk Utama Lainnya. Produk imunologi termasuk reumatologi, dermatologi, dan gastroenterologi. Produk onkologi mencakup Imbruvica, Venclexta/Venclyxto, Elahere, dan Epkinly. Portofolio estetika terdiri dari injeksi wajah, plastik dan kedokteran regeneratif, kontur tubuh, dan produk perawatan kulit. Produk ilmu sarafnya mencakup Botox Terapeutik, Vraylar, Duopa, dan Duodopa, Ubrelvy, dan Qulipta. Duodopa adalah gel usus levodopa-karbidopa untuk pengobatan penyakit Parkinson. Produk perawatan mata termasuk Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, dan Restasis. Produk utama lainnya mencakup Mavyret/Maviret, Creon, dan Linzess/Constella. Jalur produknya juga termasuk zumilokibart dan APG273.

AbbVie Stock

About AbbVie

Key Statistics

Insights